NEVVI Medicare utilization intelligence

← back

FINCH, SARAHAPRN NPI 1144978271 Clinician

Nurse Practitioner · HUTCHINSON, KS

Specialty Nurse Practitioner — from billed Medicare claims
In practice about 4 years since medical school (class of 2022, self-reported to CMS)
Location HUTCHINSON, KS · NPPES registered location
Active in data Billed Medicare 2022–2024 (3 consecutive years)
Scale 54 codes billed · 895,540 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20222026
LITTLE CLINIC OF KANSAS LLC
2025–2026
HUTCHINSON CLINIC PA INC
2022–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-03

Year: 2024 · 2023 · 2022 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J3111 Injection, romosozumab-aqqg, 1 mg
J0897 Injection, denosumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1602 Injection, golimumab, 1 mg, for intravenous use
J3380 Injection, vedolizumab, intravenous, 1 mg
J9299 Injection, nivolumab, 1 mg
J1756 Injection, iron sucrose, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9267 Injection, paclitaxel, 1 mg
J1745 Injection, infliximab, excludes biosimilar, 10 mg
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
96372 Injection of drug or substance under skin or into muscle
J2919 Injection, methylprednisolone sodium succinate, 5 mg
J0640 Injection, leucovorin calcium, per 50 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J9190 Injection, fluorouracil, 500 mg
J3489 Injection, zoledronic acid, 1 mg
J9045 Injection, carboplatin, 50 mg
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
96361 Infusion into a vein for hydration, each additional hour
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
96523 Irrigation of implanted venous access drug delivery device
96360 Infusion into a vein for hydration, 31-60 minutes
36591 Collection of blood sample from implanted device
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
J7030 Infusion, normal saline solution , 1000 cc
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
96411 Administration of additional new drug or substance into vein using push technique
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J2997 Injection, alteplase recombinant, 1 mg
36415 Insertion of needle into vein for collection of blood sample
96374 Injection of drug or substance into vein
80053 Blood test, comprehensive group of blood chemicals
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
36593 Declotting of central venous tube
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.